CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 125326-125555 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T766","span":{"begin":0,"end":229},"obj":"Sentence"},{"id":"T34626","span":{"begin":0,"end":229},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Finally, a non-virosomal intranasal influenza vaccine that used Escherichia coli heat-labile toxin as an adjuvant, previously manufactured by Berna, was removed from the market because of a possible association with Bell's Palsy."}

{"project":"Epistemic_Statements","denotations":[{"id":"T310","span":{"begin":0,"end":229},"obj":"Epistemic_statement"}],"text":"Finally, a non-virosomal intranasal influenza vaccine that used Escherichia coli heat-labile toxin as an adjuvant, previously manufactured by Berna, was removed from the market because of a possible association with Bell's Palsy."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T171","span":{"begin":0,"end":229},"obj":"Sentence"}],"text":"Finally, a non-virosomal intranasal influenza vaccine that used Escherichia coli heat-labile toxin as an adjuvant, previously manufactured by Berna, was removed from the market because of a possible association with Bell's Palsy."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T681","span":{"begin":36,"end":45},"obj":"Disease"},{"id":"T682","span":{"begin":149,"end":152},"obj":"Disease"},{"id":"T683","span":{"begin":216,"end":228},"obj":"Disease"}],"attributes":[{"id":"A681","pred":"mondo_id","subj":"T681","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A682","pred":"mondo_id","subj":"T682","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A683","pred":"mondo_id","subj":"T683","obj":"http://purl.obolibrary.org/obo/MONDO_0005665"}],"text":"Finally, a non-virosomal intranasal influenza vaccine that used Escherichia coli heat-labile toxin as an adjuvant, previously manufactured by Berna, was removed from the market because of a possible association with Bell's Palsy."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T176","span":{"begin":216,"end":228},"obj":"Phenotype"}],"attributes":[{"id":"A176","pred":"hp_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/HP_0010628"}],"text":"Finally, a non-virosomal intranasal influenza vaccine that used Escherichia coli heat-labile toxin as an adjuvant, previously manufactured by Berna, was removed from the market because of a possible association with Bell's Palsy."}